Total Payments
$29,949
2022 Payments
$246.92
Companies
23
Transactions
228
Medicare Patients
552
Medicare Billing
$65,214
Payment Breakdown by Category
Other$19,295 (64.4%)
Food & Beverage$3,923 (13.1%)
Travel$3,568 (11.9%)
Consulting$2,830 (9.4%)
Education$333.27 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,295 | 13 | 64.4% |
| Food and Beverage | $3,923 | 187 | 13.1% |
| Travel and Lodging | $3,568 | 18 | 11.9% |
| Consulting Fee | $2,830 | 1 | 9.4% |
| Education | $333.27 | 9 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $27,102 | 69 | $0 (2020) |
| ViiV Healthcare Company | $821.17 | 44 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $685.67 | 50 | $0 (2020) |
| The Medicines Company | $285.96 | 15 | $0 (2017) |
| ABBVIE INC. | $262.68 | 10 | $0 (2022) |
| Janssen Products, LP | $168.99 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $148.76 | 11 | $0 (2020) |
| Theratechnologies Inc. | $123.94 | 5 | $0 (2019) |
| Melinta Therapeutics, Inc. | $52.85 | 3 | $0 (2019) |
| TETRAPHASE PHARMACEUTICALS, INC. | $36.36 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $246.92 | 10 | ViiV Healthcare Company ($135.28) |
| 2021 | $217.94 | 5 | ViiV Healthcare Company ($114.95) |
| 2020 | $302.30 | 18 | ViiV Healthcare Company ($77.37) |
| 2019 | $888.47 | 40 | Gilead Sciences, Inc. ($380.17) |
| 2018 | $10,970 | 64 | Gilead Sciences, Inc. ($10,373) |
| 2017 | $17,323 | 91 | Gilead Sciences Inc ($16,314) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: HIV | ||||||
| 07/28/2022 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/06/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: HIV | ||||||
| 06/17/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: HIV | ||||||
| 06/17/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: HIV | ||||||
| 06/02/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: HIV | ||||||
| 05/18/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: HIV | ||||||
| 04/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: HIV | ||||||
| 04/06/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/16/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $91.47 | General |
| Category: HIV | ||||||
| 12/01/2021 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $69.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/30/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $33.00 | General |
| Category: ANTIBIOTIC | ||||||
| 09/21/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: HIV | ||||||
| 08/16/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: HIV | ||||||
| 08/11/2021 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $91.31 | General |
| Category: HIV | ||||||
| 10/29/2020 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14.53 | General |
| Category: Infectious Disease | ||||||
| 10/16/2020 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 10/15/2020 | VYERA PHARMACEUTICALS, LLC | Daraprim (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Toxoplasmosis | ||||||
| 09/25/2020 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/17/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/20/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.19 | General |
| 08/05/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: HIV | ||||||
| 07/29/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: HIV | ||||||
| 07/27/2020 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/25/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 284 | 384 | $135,222 | $28,076 |
| 2021 | 5 | 146 | 171 | $47,724 | $10,888 |
| 2020 | 6 | 122 | 259 | $73,900 | $26,249 |
Total Patients
552
Total Services
814
Medicare Billing
$65,214
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 158 | $70,990 | $13,315 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 89 | $26,989 | $5,379 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $18,708 | $2,971 | 15.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 21 | 21 | $4,750 | $2,771 | 58.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $7,834 | $1,669 | 21.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 27 | $2,331 | $764.44 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 25 | $2,213 | $702.71 | 31.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 22 | 24 | $1,407 | $504.48 | 35.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 57 | $25,023 | $5,747 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 64 | $18,944 | $4,255 | 22.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 17 | 17 | $952.00 | $349.01 | 36.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 16 | 17 | $1,445 | $276.42 | 19.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $1,360 | $260.16 | 19.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 13 | 62 | $34,028 | $10,696 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 78 | $16,014 | $6,240 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 70 | $9,497 | $3,925 | 41.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 20 | $7,597 | $3,080 | 40.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $5,695 | $1,836 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 11 | 12 | $1,070 | $472.64 | 44.2% |
About Dr. James Powers, M.D
Dr. James Powers, M.D is a Infectious Disease healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962602516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Powers, M.D has received a total of $29,949 in payments from pharmaceutical and medical device companies, with $246.92 received in 2022. These payments were reported across 228 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,295).
As a Medicare-enrolled provider, Powers has provided services to 552 Medicare beneficiaries, totaling 814 services with total Medicare billing of $65,214. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease, Infectious Disease
- Location Greensboro, NC
- Active Since 07/23/2007
- Last Updated 10/03/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1962602516
Products in Payments
- Epclusa (Drug) $15,138
- Vosevi (Drug) $4,764
- DOVATO (Drug) $276.64
- Biktarvy (Drug) $243.66
- MINOCIN IV (Drug) $237.61
- ZERBAXA (Drug) $205.65
- SYMTUZA (Drug) $184.64
- ISENTRESS (Drug) $178.40
- TRIUMEQ (Drug) $169.37
- TIVICAY (Drug) $159.38
- Viekira (Drug) $136.52
- JULUCA (Drug) $104.91
- RUKOBIA (Drug) $91.31
- DELSTRIGO (Drug) $90.77
- Odefsey (Drug) $90.75
- EGRIFTA (Drug) $78.73
- Mavyret (Drug) $73.29
- Cresemba (Drug) $69.76
- DIFICID (Drug) $64.94
- Vabomere (Drug) $52.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Greensboro
Cornelius Van Dam, M.d, M.D
Infectious Disease — Payments: $513,067
Infectious Disease $513,067
Stephanie Dixon, Fnp-C, FNP-C
Infectious Disease — Payments: $2,696
Infectious Disease $2,696
Dr. Jeffrey Hatcher, M.d, M.D
Infectious Disease — Payments: $2,477
Infectious Disease $2,477
Trung Vu, Md, MD
Infectious Disease — Payments: $891.86
Infectious Disease $891.86